CBU
EW icon

CIBC Bancorp USA’s Edwards Lifesciences EW Stock Holding History

CIBC Bancorp USA’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17M Sell
187,914
-37,436
-17% -$3.14M 0.02% 443
2026
Q1 		$18M Buy
+225,350
New +$18.6M 0.02% 389
2025
Q3 		$6.3M Buy
+80,982
New +$6.33M 0.03% 356

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

CIBC Bancorp USA's EW Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Edwards Lifesciences (EW) stake by 17% in Q2 2026, selling an estimated $3.14M and leaving 187,914 shares worth $17M. The position accounts for 0.02% of the portfolio, ranked #443.

CIBC Bancorp USA first reported a position in EW in Q3 2025 and has held it in 3 quarters since. The position peaked at $18M in Q1 2026. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • CIBC Bancorp USA held 187,914 shares of Edwards Lifesciences worth $17M as of Q2 2026.
  • CIBC Bancorp USA sold 37,436 Edwards Lifesciences shares in Q2 2026, an estimated $3.14M.
  • Edwards Lifesciences made up 0.02% of CIBC Bancorp USA's portfolio in Q2 2026, its #443 holding.
  • CIBC Bancorp USA first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Edwards Lifesciences position peaked at $18M in Q1 2026.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.